Published in Blood Weekly, May 11th, 2006
Study 1: Detection of bone marrow lesions was improved by ferumoxtran-10-enhanced MR imaging.
According to a recent report, researchers in Germany conducted a study "to quantify permeability changes of the 'blood-bone marrow barrier' (BMB) and to detect malignant bone marrow infiltrations before and after conditioning therapy for subsequent leukapheresis using ferumoxtran-10-enhanced magnetic resonance (MR) imaging. Twenty-two patients with malignant non-Hodgkin lymphomas (NHL), including 9 patients (group A) before and 13 patients (group B) after conditioning therapy,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.